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Abstract
Blood supply is a critical issue in most tissue engineering 
approaches for large defect healing. As vessel ingrowth 
from surrounding tissues is proven to be insufficient, current 
strategies are focusing on the neo-vascularisation process.
 In the present study, we developed an in vitro pre-
vascularised construct using 3D polyurethane (PU) 
scaffolds, based on the association of human Endothelial 
Progenitor Cells (EPC, CD34+ and CD133+) with human 
Mesenchymal Stem Cells (MSC). We showed the formation 
of luminal tubular structures in the co-seeded scaffolds as 
early as day 7 in culture. These tubular structures were 
proven positive for endothelial markers von Willebrand 
Factor and PECAM-1. Of special significance in our 
constructs is the presence of CD146-positive cells, as a 
part of the neovasculature scaffolding. These cells, coming 
from the mesenchymal stem cells population (MSC or 
EPC-depleted MSC), also expressed other markers of 
pericyte cells (NG2 and αSMA) that are known to play a 
pivotal function in the stabilisation of newly formed pre-
vascular networks. In parallel, in co-cultures, osteogenic 
differentiation of MSCs occurred earlier when compared 
to MSCs monocultures, suggesting the close cooperation 
between the two cell populations. The presence of 
angiogenic factors (from autologous platelet lysates) in 
association with osteogenic factors seems to be crucial 
for both cell populations’ cooperation. These results are 
promising for future clinical applications, as all components 
(cells, growth factors) can be prepared in an autologous 
way.
Keywords: Mesenchymal stem cells; endothelial progenitor 
cells; bone; neovascularisation; 3D; co-cultures; autologous; 
platelet lysates.
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Introduction
Bone is a highly vascularised tissue that generally leads to 
spontaneous regeneration of shape and function without 
scar formation (Salgado et al., 2004). During bone 
remodelling and repair, new capillaries derived from 
pre-existing neighbour vessels invade the site through 
angiogenesis (Carano and Filvaroff, 2003). Thus, the best 
healing rates of injuries occur mainly in areas with the 
highest level of vascularisation (Deleu and Trueta, 1965; 
Novosel et al., 2011).
 In cases of large bone defects, not only is the bone 
tissue damaged, but the surrounding vasculature is often 
notably debilitated, impairing adequate levels of oxygen 
and nutrient supply at the injury site and ultimately proper 
healing (Rhinelander, 1965; Johnson et al., 2011). With 
a growth rate of around 5 µm/h, sprouting-out from 
existing vessels is limited in space, and a time-consuming 
process that requires the presence of blood vessels in the 
immediate surroundings (Laschke and Menger, 2012).
 Bone repair highly depends on the presence of 
osteogenic cells at the healing site (Mandracchia et al., 
2001; Carano and Filvaroff, 2003), and bone marrow is 
a natural reservoir of skeletal stem cells. Recruitment, 
proliferation and differentiation of MSCs into mature 
osteoblasts are regulated by many factors including 
cytokines, growth factors and systemic hormones. 
These factors are released not only by osteoblastic cells 
themselves (Lian and Stein, 1995), but also by cells that 
are part of the tightly connected vascular system, such as 
endothelial cells (Wang et al., 1997; Street et al., 2002; 
Villars et al., 2002; Fuchs et al., 2007) and pericytes (Jones 
et al., 1995).
 Many studies underline the close relationship between 
angiogenesis and ontogenesis. Cross-talk between 
endothelial cells and osteoblasts has been reported, 
through secreted factors (e.g., VEGF) and through direct 
cell-cell interactions (e.g., cell surface proteins, gap 
junctions) (Villars et al., 2000; Meury et al., 2006; Grellier 
et al., 2009; Santos et al., 2009). Based on this knowledge, 
contemporary advances focus on neovascularisation of 
tissue-engineered bone implants (Rafii and Lyden, 2003; 
Unger et al., 2007; Hofmann et al., 2008; Laschke et 
al., 2008; Fuchs et al., 2009; Capobianco et al., 2010). 
Postnatal neovascularisation is thought to exclusively 
result from proliferation, migration, and remodelling of 
fully differentiated endothelial cells (EC) sprouting from 
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existing vessels (angiogenesis). In contrast, vasculogenesis, 
which occurs during embryo development, involves blood 
vessel formation from endothelial progenitor cells (EPC), 
also called angioblasts. Recent cumulative evidence 
indicates that peripheral blood of adults contains bone-
marrow derived progenitor EPCs with properties similar 
to those of embryonic angioblasts (Asahara et al., 1997; 
Gehling et al., 2000; Hristov et al., 2003; Hristov and 
Weber, 2004; Zammaretti and Zisch, 2005). A fundamental 
advantage of EPCs is that they can be isolated from the 
patient’s own blood and bone marrow.
 The aim of the present study was to develop a pre-
vascularised bone implant that would enable a faster 
blood supply throughout implanted tissue-engineered bone 
constructs. To our knowledge, no study has elucidated the 
neovascularisation potential of EPCs co-cultured with 
MSCs in a 3D environment.
 Firstly, we examined the ability of EPCs alone, or in 
association with MSCs, to develop mature endothelial 
cell properties in a 2D cell culture environment. Secondly, 
these two cell populations were cultured on their own, or 
in association within a polyurethane 3D scaffold. Several 
cell-culture conditions were tested, including autologous 
Platelet Rich Plasma (PRP) and Platelet Lysate growth 
factors (PL), in order to establish the optimal condition 
for both cell types (Lippross et al., 2011).
Materials and Methods
Cell culture media
For the co-culture of different cell types (EPC / HUVEC 
and MSC), different cell culture media compositions were 
tested. The Iscove Modified Dulbecco’s Medium (IMDM), 
Foetal Calf Serum (FSC), Non-Essential Amino Acids 
(NEAA) and antibiotics (PenStrep, PS) were all from 
Gibco/Invitrogen Life Technologies (Zug, Switzerland). 
The Basic Fibroblast Growth Factor (bFGF) was from 
R&D Biosystems (Minneapolis, MN, USA). Ascorbic 
acid, β-glycerophosphate and dexamethasone were all 
from Sigma-Aldrich (Hamburg, Germany). M200 plus 
Low Serum Growth Supplement (LSGS) was purchased 
from Cascade Biologics (Portland, OR, USA).
Medium 1: IMDM-5 % FCS-5 % PL growth factors
Medium 2: M200-LSGS 
Medium 3: 50 % Medium 1 + 50 % osteogenic medium 
(IMDM-10 % FCS-10 nM dexamethasone – 10 mM 
β-glycerophosphate – 0.1 mM Ascorbic acid)
Medium 4: 50 % Medium 2 + 50 % osteogenic medium.
PL and PRP preparation
Platelet Lysate growth factors (PL) and Platelet Rich 
Plasma (PRP) were prepared from platelet concentrates, 
as described earlier (Verrier et al., 2010; Lippross et al., 
2011). Platelet bags were obtained from the blood bank 
of Kantonspital Graubünden in Chur (Switzerland) in 
accordance with the current ethical laws of Switzerland. 
The platelet bags contain a standardised platelet density 
(5 times higher than normal), obtained through blood 
apheresis. We further increased the platelet density 
by a centrifugation at 2000 g for 7 min, followed by 
resuspension of the pellet in half of the original platelet-
bag volume. Phosphate buffered saline (PBS) was used 
for the PL preparations, while original plasma was used 
for the PRP preparations, to obtain a final concentration 
10 times higher than normal blood (2.5 million (± 10 %) 
platelets/µL). PL and PRP samples were pooled from three 
different platelet concentrates and randomly matched. The 
quality of the samples was tested by ELISA (DuoSet, R&D 
Biosystems) dosage of PDGF-AB, PDGF-BB and VEGF 
on a Perkin Elmer (Waltham, MA, USA) Victor3 Reader 
1420-050. As expected, the concentrations we obtained (3 
mixes of 3 donors, and 3 individual donors) were about 
10 times higher than the range measured in blood plasma 
(Table 1).
Cell isolation 
Human bone marrow aspirates (20 mL) were obtained upon 
informed consent and ethical approval (KEK Bern 126/03) 
from 5 donors (44 to 83 years old, average age 62 years; 
4 males and 1 female) undergoing routine orthopaedic 
surgery. The samples were collected in CPDA-containing 
Sarstedt S-Monovettes (Sarstedt, Nümbrecht, Germany) 
and processed within 12-24 h after harvesting.
Mesenchymal Stem Cells (MSC)
MSCs were isolated from bone marrow aspirates by 
Histopaque-1077 (Sigma-Aldrich) density gradient 
centrifugation. As previously described (Martin et al., 
1997; Meury et al., 2006), bone marrow was homogenised 
and diluted 1:4 with IMDM containing 5 % FCS.  After 
slowly pipetting onto the Histopaque, the samples 
Table 1. PRP/PL protein content. PDGF-AB, PDGF-
BB, and VEGF concentration in several PL and PRP 
preparations were quantified by ELISA. The results 
are presented in ng/mL ± standard deviation. No major 
differences could be observed between samples from 
different donors, or different pools (mixes of 3 donors).
PDGF-AB PDGF-BB VEGF
PL 
Samples
ng/mL 
± sd
ng/mL 
± sd
ng/mL 
± sd
Mix 1
7.570 
± 1.772
5.677 
± 0.848
0.567 
± na
Mix 2
67.491 
± 10.321
7.359 
± 1.216
1.517 
± 0.323
Mix 3
26.436 
± 2.404
4.674 
± 0.958
0.761 
± na
donor 1 46.549 ± 3.245
9.673 
± 0.892
1.084 
± 0.195
donor 2 63.885 ± 10.208
11.141 
± 1.537
1.902 
± 0.211
donor 3 28.701 ± 2.718
4.522 
± 0.310
1.299 
± 0.211
PRP: Platelet Rich Plasma, PL: Platelet Lysate, PDGF: 
Platelet Derived Growth Factor, VEGF: Vascular 
Endothelial Growth Factor, sd: standard deviation, na: 
not available.
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were centrifuged at 800 g for 20 min. The low-density 
mononucleated cell interphase was collected and washed 
twice in 5 mL of IMDM 10 % FCS, followed by 15 min 
centrifugation at 400 g.
Endothelial Progenitor Cells (EPC)
EPCs (CD34+/CD133+) were further selected from the 
previously isolated MSCs using magnetic microbeads 
linked to antibodies specific to CD34 (MACS system, 
Miltenyi Biotec, Bergisch Gladbach, Germany), according 
to the manufacturer’s instructions. To confirm their EPC 
phenotype, the selected cells were characterised by FACS 
analysis (BD FACS AriaIII, BD Biosciences, Allschwil, 
Switzerland) using CD34, CD133 and CD309 specific 
antibodies (Miltenyi Biotec) and their ability to incorporate 
Dil AcLDL (Invitrogen, Basel, Switzerland). The EPC-
depleted population was called minus-minus (MM).
Human Umbilical Vein Endothelial Cells (HUVEC)
HUVECs (Cascade Biologics) were used as an endothelial 
cell positive control.
Cell amplification
Cells were counted using a haemocytometer chamber under 
a bright field microscope, seeded at the initial density of 
10,000 cells/cm2 in cell culture flasks (Techno Plastic 
Products, Trasadingen, Switzerland) and cultured in the 
appropriate cell culture medium as follows:
• MSCs and MM cells were amplified in IMDM, 
containing PenStrep (100 U/ml), 10 % FCS, 1 % 
NEAA and 5 ng/mL bFGF.
• EPCs were cultured in Medium 1.
• HUVECs were cultured in Medium 2.
All cell types were cultured at 37 °C in a 5 % CO2 
humidified atmosphere incubator, with the media changed 
twice a week. Cells between passages 2 and 4 were 
subsequently used.
Cell co-cultures
2D MatrigelTM tube formation assay
Cell culture wells (3.6 cm2) were coated with 50 µL/cm2 
of Growth Factor reduced MatrigelTM (BD Biosciences). 
Prior to seeding, EPCs and HUVECs were labelled 
using PKH67-green® (Sigma-Aldrich).  MSCs and MM 
cells were labelled using PKH26-red® (Sigma-Aldrich). 
HUVECs were used as a positive control for cellular 
network formation. Ten thousand cells were seeded in each 
well. Cells were either seeded as a single cell type (one 
cell type per well) or co-seeded with another cell type in a 
50-50 ratio (MSC+HUVEC, MSC+EPC, MM+HUVEC, 
MM+EPC). Samples were cultured in Medium 1 for short 
incubation time, and in Medium 3 for longer time (7 days). 
Each condition was seeded in triplicate, and was repeated 
using cells from 3 different donors. Cells were incubated 
for 1, 5, 24 hours and 7 days at 37 °C in a 5 % CO2 
incubator. Samples were then observed by epifluorescence 
microscopy using an inverted microscope Axiovert 200M 
with Axiovision software (Carl Zeiss, Jena, Germany).
3D cell culture
Bioresorbable elastomeric polyurethane (PU) scaffolds 
containing nanoparticles of hydroxyapatite (HA) were 
used throughout all experiments (Gorna and Gogolewski, 
2000; Gorna and Gogolewski, 2003; Laschke et al., 
2010). The scaffolds represented a volume of 9 mm3 
(1 mm x 3 mm x 3 mm) and an open porosity with a 
pore size of 200-630 µm (Gorna and Gogolewski, 2006). 
The scaffolds were seeded with 70,000 cells each in 
different cell type combinations as described for the 
MatrigelTM experiments, but without cell pre-staining. 
Cells were trypsinised, counted as previously described, 
and resuspended in PRP (3 μL/scaffold) in the presence 
of thrombin (5 U/mL final) to promote gelification. 
These cell/PRP preparations were rapidly soaked into the 
elastomeric PU scaffolds (sponge effect) enabling a deep 
and even repartition of the cells within the structure. The 
cell-seeded scaffolds were cultured in a 37 °C and 5 % 
CO2 incubator in the presence of Medium 1, Medium 
2, Medium 3 or Medium 4. The scaffolds were seeded 
and analysed for each condition in duplicate (histology 
staining, immunostaining, tubular structure quantification), 
and the whole experiment was repeated with cells from 3 
different donors.
Immunostaining
2D co-culture immunocytochemistry
In order to characterise the cells participating in the cellular 
network formation, immunostaining was performed 
using CD146-specific antibodies (Abcam, Cambridge, 
UK). MatrigelTM samples were fixed for 10 min in PBS 
containing 5 % glutaraldehyde (Agar Scientific, Stansted, 
UK) then rinsed for 10 min in distilled water. After washing 
for 5 min in PBS and blocking non-specific binding sites 
by incubating 1 h in a 1:20 goat serum solution, samples 
were incubated for 30 min in the CD146-specific antibody, 
diluted 1:1000. After 3 washing steps for 5 min each in 
PBS-Tween, the secondary antibody fluorescent blue Alexa 
Fluor 350 (Invitrogen/Life Technologies) was added in a 
1:200 dilution and incubated for 30 min. Samples were 
then washed for 5 min  in PBS-Tween, and were viewed 
microscopically while in PBS.
3D co-cultures immunohistochemistry
After 7 days, the scaffolds were transferred into wells 
containing “Tissue freezing media” (Leica Microsystems, 
Nussloch, Germany) for cryosectioning. After snap-
freezing in isopentane (Sigma-Aldrich) cooled in liquid 
nitrogen, the frozen scaffolds were sectioned (10 μm) 
using a Microm HM 560 microtome (Thermo Scientific, 
Walldorf, Germany), and collected on Superfrost Plus® 
microscope slides (Gerhard Menzel, Braunschweig, 
Germany). Sections were preserved at -20 °C until use.
 Cryosections were fixed in 70 % methanol for 15 min 
and rehydrated in PBS for 10 min. The slides were 
incubated for 30 min in methanol containing 0.3 % H2O2 
to block endogenous peroxidase, then transferred to a moist 
chamber for the staining processes. After blocking non-
specific sites with a 1 h incubation in horse serum (diluted 
1:20 in PBS-Tween, Vector Labs, Burlingame, CA, USA), 
52 www.ecmjournal.org
F Duttenhoefer et al.                                                                   EPC and MSC co-culture promotes neovascularisation
samples were incubated for 30 min in the primary antibody 
diluted at the optimal concentration: von Willebrand Factor 
(vWF)(F8-86, Signet 115-01; Covance, Princeton, NJ, 
USA) was used at 1:400 and CD146 (Abcam) at  1:1000. 
αSMA (Abcam), NG2 (Abcam), and PECAM-1 (R&D 
Systems) were diluted to a final concentration of 0.5 μg/
mL, 3.85 μg/mL, and 1 μg/mL, respectively. The primary 
antibodies were omitted and replaced by PBS-Tween for 
the negative controls. After 3 washings in PBS-Tween, 
the secondary antibodies were added and incubated for 
30 min. Biotinylated goat anti-rabbit (dilution 1:200, Vector 
Labs: BA-1000) was used to detect the vWF antibody. A 
biotinylated horse anti-mouse (Vectastain ABC kit, Vector 
Labs), at a dilution of 1:200, was used to detect the CD146 
and PECAM antibodies. After washing in PBS-Tween, 
antibodies were visualised with the Vectastain Elite ABC 
kit and DAB (both Vector Labs). Slides were cover-slipped 
with Prolong Gold Antifade reagent with DAPI (for 
nuclear counterstain) (Invitrogen/Molecular Probes). For 
digital photographic documentation an Axioplan upright 
microscope with Axiovision software (Carl Zeiss) was 
used.
Tubular structures quantification
Tubular structures were quantified by manual counting 
performed by 2 different observers. Five fields of view 
were counted per section taken from separate samples 
(2 sections per sample, 2 samples per donor, 3 donors). 
Results were analysed by one-way analysis of variance 
(ANOVA) corrected by Bonferoni (SPSS software/IBM, 
Armonk, NY, USA) (*: p < 0.05, **: p < 0.01).
Results
Cell characterisation
Total bone marrow mononucleated cells (Histopaque 
interphases) and EPCs (post Miltenyi magnetic microbeads 
isolation) from 5 donors were characterised by FACS 
analyses (Table 2) . After Histopaque isolation, about 6 % 
of the total cells were CD34+, from which 0.4 % were 
CD34/CD133 positive. After the EPCs’ enrichment, around 
11 % of the CD34+ cell population was also CD133+. The 
number of triple positive cells (CD34+/CD133+/CD309+) 
was quite low, which can be explained by the fact that the 
post-enrichment cell populations were analysed at later 
passages (> p4). However, around 75 % of the cells were 
able to incorporate Dil acLDL.
MatrigelTM tubular structure assay
After amplification in the corresponding cell growth 
media, the different cell types were seeded on reduced 
growth factor MatrigelTM either on their own (HUVEC, 
MSC, EPC, MM) or in association with another cell type 
(MSC/HUVEC, MSC/EPC, MM/HUVEC, MM/EPC), and 
incubated for different periods of time at 37 °C and 5 % CO2 
with Medium 1. After 4 h HUVECs migrated towards each 
other and started to establish cell-cell interactions (Fig. 
1a)  that got more structured after longer incubation times 
(Fig. 1b). We could detect a similar network formation in 
EPCs cultures. Already after 4 h in culture, EPCs formed 
a cellular network (Fig. 1c) that became more structured 
after 24 h (Fig. 1d). At the same observation time points, 
MSCs alone or the MM cell fraction (Figs. 1e-g) only 
adhered and started to present cytoplasmic extensions. At 
24 hours, some cells in the MSC cultures (Fig. 1f) also 
started to organise a cellular network, while MM cells 
never showed such structures (Fig. 1h).
 When EPCs were added to the MSCs or to the MM cell 
populations (in presence of Medium 1), a rapid (already 
after 5 h, Figs. 2a-b) and complex cellular network could 
be observed involving both EPCs (stained in green) and 
some cells (but not all) from the MSC or MM populations 
(stained in red). This cellular network became more 
organised over time (Figs. 2c-d), forming tubular-like 
structures (representative pictures of 3 donors). In order 
to investigate the nature of the cells from the MSC or MM 
populations that were enrolled in the cellular network, 
we performed some immunostaining using a CD146-
specific antibody at different time points of co-culture on 
MatrigelTM (5 h, 24 h and 7 days). After 5 and 24 h, no 
CD146 staining could be observed. However, after 7 days 
(Fig. 3) some cells showed a positive signal for CD146. 
Fig. 3a (phase contrast microscopy) shows the aspect of the 
EPC/MSC co-culture after 7 days incubation in Medium 
3. In contrast to the previous MatrigelTM results (Fig. 2) 
where the cells had a “3-dimensional” shape, after 7 days 
the cells grew much more and adopted a more flattened 
Table 2. FACS characterisation of full bone marrow mononucleated cell population and 
EPC enriched population. Samples were analysed directly after histopaque density gradient 
and percentages of CD34+, CD133+, and CD309+ single or double positive populations 
were established. The same was performed after EPC enrichment through the Miltenyi 
microbeads system (CD34+). Samples from 5 different donors were tested, and results are 
presented as percentage of the tested population ± standard deviation. (nd =  not detected).
Bone marrow populations post EPC enrichment
CD34+ 6.2 ± 3.9 % 73.5  ± 24.3 %
CD34+/CD133+ 0.46 ± 0.37 % 10.9  ± 15 %
CD133+ 0.3  ± 0.26 % nd
CD309+ 0.2  ± 0.14 % 0.15  ± 0.07 %
CD34+/CD309+ nd 0.15  ± 0.07 %
Lectin uptake 1 % 45.2 %
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Fig. 1. Tube formation capacity of the different cell types on MatrigelTM assays. Images are representative pictures 
from wells seeded in triplicate using cells from 3 different donors. After cell amplification in Medium 2 (HUVEC, 
a-b), Medium 1 (EPC, c-d) or IMDM 10 % FCS (MSC, e-f and MM, g-h), each population was seeded on a thin 
layer of MatrigelTM in the presence of Medium 1. Pictures were taken using contrast phase microscopy after 4 h (a, 
c, e, g) and 24 h (b, d, f, h) incubation in a 37 °C and 5 %CO2 incubator. After 4 h, HUVECs, EPCs started to form 
a cellular network (a, c) increasing afterwards (d, e), while no such organised cell interaction was observed with 
MSCs (e, f) or MM population (g, h).
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appearance on most of the surface. Only a few places 
still showed “3-dimensional” cells, and when observed 
under fluorescent microscopy, the pre-stained EPCs 
appeared green (Figs. 3b-d) while the MSCs appeared 
red (Figs. 3c-d). CD146 staining was only observed in 
the “3-dimensional” cell areas. No staining was observed 
in the surrounding flattened cells, due to the fact that the 
pre-staining dyes (PKH67 and PKH26) fade upon cell 
proliferation. On the merged picture of the three stainings 
(Fig. 3d), CD146 staining (in blue) appears co-localised 
with the red staining (MSCs), indicating that only cells 
from the MSC fraction expressing CD146 were enrolled 
in the cellular network. The same observation was made 
for the MM cells (data not shown).
3D co-culture
Based on the results of the MatrigelTM assays, cells were 
seeded in 3D scaffolds in different conditions. MSCs 
were cultured alone, or in association with either EPCs 
or HUVECs in the ratio of 75 %:25 % and 50 %:50 %, 
respectively (MSC-EPC, MSC-HUVEC). As different 
cell types have different requirements, and 3D co-cultures 
are long-term experiments, four media were tested (see 
Materials & Methods section). Each condition was seeded 
with cells from 3 donors in duplicate.
Cell organisation within the scaffolds
After 7 days of culture, the scaffolds were processed for 
cryosectioning. Ten µm sections were made and stained 
with toluidine blue.
 As seen in Fig. 4 (a-h), both media containing 
dexamethasone (Medium 3 and Medium 4) showed a 
well-established and more “stroma-like” extracellular 
matrix, as compared to the media conditions without (data 
not shown). Figures 4a and b show the scaffolds that were 
seeded with MSCs only, while Figs. 4c to f show the MSCs 
cultured with HUVECs (c-d), or with EPCs (e-f). When 
cells were co-cultured in a 75 %:25 % ratio (c-f), circular 
structures with intercellular lumen could be observed 
(white arrows). These cellular rearrangements became 
slightly more abundant and organised when the percentage 
of EPCs seeded was increased to 50 % (g-h). When MSCs 
were cultured alone (Figs. 4 a-b), such structures were 
significantly less abundant. When scaffolds containing 
Fig. 2. Mesenchymal stem cells participate in the formation of a tubular network. Cells from 3 donors were seeded on 
growth factor reduced MatrigelTM (n = 3). 50 % EPCs (in green) were co-seeded either with 50 % MSCs (in red) (a, 
c) or with 50 % MMs (in red) (b, d). Cells were incubated for 4 h (a, b) or 24 h (c, d) in the presence of Medium 1, 
and observed with epifluorescence microscopy. After 4 h, both co-cultures exhibit an early cellular network formation 
with both cell types participating (a, c). After 24 h, more complex cellular/tubular networks are produced (b, d).
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co-cultures or a single cell type were cultured in Medium 
1 or Medium 2, reorganisation into circular structures was 
never observed (data not shown). Therefore, subsequent 
experiments were conducted in Medium 3 and Medium 4.
 To further investigate the three dimensional distribution 
of these cells, sequential sectioning of the same scaffolds 
was performed. Circular structures were found at similar 
locations on serial sections (Fig. 5). Cryosections 
separated from each other by about 80 µm were stained 
with toluidine blue (Figs. 5 a,b). The same lumen could 
be followed over sections (dashed arrow). When sections 
were stained with the endothelial cell marker antibody 
PECAM-1 (Figs. 5c-d), the circular structures were well 
distinguished (section c), and still present at a distance 
of more than 100 µm (dashed arrows, section d). This 
suggests that the assemblies previously described as 
circular structures are in fact cross-sections of luminal 
tubular structures present within the 3D scaffolds. These 
were always identified in co-culture conditions, but 
only in the presence of dexamethasone (media 3 and 4). 
When MSCs were cultured on their own, such structures 
could never be observed, independent from the culture 
medium used. Therefore, all subsequent experiments were 
performed using Medium 3, and scaffolds seeded with 
either 100 % MSCs, or a 50 %:50 % ratio of MSC:HUVEC 
or MSC:EPC.
Characterisation of the cells involved in the tubular 
structures
Cells involved in the tubular structures were further 
characterised by immunohistochemistry (Fig. 6). As shown 
by the DAPI nuclei staining (in blue), cells were well 
distributed across the scaffolds. Using a PECAM-1-specific 
antibody (Figs. 6a- c), endothelial cells were detected only 
in co-culture conditions (b-c) and exclusively on cells 
participating in the tubular arrangements (white arrow 
heads). The same staining localisation could be observed 
using a vWF-specific antibody (Figs. 6d-f), where most of 
the positive staining was in the cells participating in the 
tubular-like structures. In the scaffolds seeded with only 
MSCs (Figs. 6a and d), no staining for PECAM-1 or vWF 
could be detected.
Fig. 3. Characterisation of the cells participating to the cellular network. MatrigelTM was co-seeded with 50 % of 
pre-labelled MM cells (red) and 50 % of pre-stained EPCs (green). Samples were cultured for 7 days in Medium 3, 
and then stained using a CD146-specific antibody (blue). After 7 days of culture in Medium 3, the cells proliferated 
forming a confluent monolayer and tubular structures could only be observed in some places. (a) General view of 
the co-culture (contrast phase), (b, c, d) epifluorescence observation, (b) EPCs, (c) EPCs (green) and MMs (red), 
(d): merged picture showing EPCs (green) and MM expressing CD146 (co-localisation of red and blue staining). 
(Representative pictures of 3 separate experiments seeded in triplicate).
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Fig. 4. Cell re-organisation in 3D co-cultures. Two scaffolds per condition and per donor were seeded and incubated 
for 7 days, then cryosectioned and stained with toluidine blue. Cells were seeded in PU-HA scaffolds in the presence 
of PRP and cultured in Medium 3 (a, c, d, e) or Medium 4 (b, d, f, g). MSCs seeded on their own (a and b), MSCs 
cultured with HUVECs in a 75 %:25 % ratio (c and d). MSCs cultured with EPCs in a 75 %:25 % ratio (e and f). MSCs 
co-seeded with EPCs in a 50 %:50 % ratio (g and h). White stars show PU-HA material and cellular re-organisation 
within the matrix, observed exclusively in co-culture cases (white arrows).
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Fig. 5. Sequential sectioning of PU-HA scaffolds (2 scaffolds per donor). Cryosections (10 µm) were stained with 
basic toluidine blue staining (a, b) or using PECAM-1-specific antibody (c, d) after 7 days of MSC and HUVEC 
co-culture (50 % each). The sections stained with toluidine blue (a, b) or with PECAM-1 (c and d) are the first 
and the last one of a sequence of 8 sections respectively, representing a distance of 80 µm in between (a) and (b) 
and around 100 µm between (c) and (d). In both stainings, cellular reorganisation could be followed over the two 
represented sections (dashed arrows), indicating that these PECAM-1-positive structures represent an inter-tubular 
lumen extended over a few hundred µm.
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 Likewise, CD146 (detected in mature endothelial cells 
and pericytes) was not detected when MSCs were cultured 
alone (Fig. 6g). However, in co-cultures, CD146 staining 
was concentrated mainly at the periphery of the tubular 
assemblies (Figs. 6h-i), as with the other endothelial cell 
markers.
Further characterisation of pericytes
As CD146 can be detected on different cell types (e.g., 
mature endothelial cells, mural cells), we performed 
additional immunostainings using NG2 and αSMA specific 
antibodies. As previously mentioned, cryosections were 
collected sequentially (Fig. 7), and the overall distribution 
of cells in the scaffolds was detected using DAPI nuclear 
staining. Positive labelling at the level of the tubular-like 
structures was obtained for each of the 3 markers on 3 
consecutive sections, but only in co-cultured scaffolds 
(MSC/EPC, MSC/HUVEC) (Figs. 7a-f, white circles). 
Unstained cells could be detected by counterstaining with 
DAPI (representative pictures of scaffolds seeded with 
cells from 3 different donors).
Quantification of mature pre-vascular structures
The number of tubular-like structures was quantified 
from the toluidine blue staining. As shown in Fig. 8a, a 
significantly higher number of these pre-vascularisation 
features were found in the scaffolds seeded with MSCs 
together with 25 % EPCs, as compared to MSCs alone. 
Those features increased even more when 50 % EPCs were 
used. When stained with mature endothelial cell markers 
(PECAM-1 and vWF) and a pericyte marker (CD146), 
a clear prevalence of “mature” tubular structures was 
observed in the constructs containing EPCs, as compared 
to those seeded with MSCs alone (Fig. 8b). These luminal 
structures were more mature (PECAM-1, vWF and CD146 
triple positive) and abundant (around 60 % more) in 
MSC-HUVEC constructs (mature endothelial cells) when 
compared to MSC-EPC co-cultures (data not shown).
Fig. 6. Immunohistochemical staining of the 3D constructs after 7 days of culture in Medium 3. MSCs were cultured 
either alone (a, d, g), with 50 % HUVECs (b, e, h) or with 50 % EPCs (c, f, i). When MSCs were co-cultured with 
HUVECs or EPCs, the presence of tubular structures positive for PECAM-1 (b, c), vWF (e, f) and CD146 (h, i) 
could be detected (white arrow heads), while none could be detected for the MSCs-only condition (a, d, g). The 
overall cell distribution was detected using DAPI nuclear staining (in blue).
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Fig. 7. Pericyte participation in the tubular structures was shown by immunohistochemistry performed on successive 
cryosections of the constructs, using CD146 (a, d), NG2 (b, e) and αSMA (c, f) antibodies. In scaffolds seeded with MSC/
EPC (50:50 ratio) (a, b, c), a positive staining could be observed for the 3 pericyte markers, at the same location over 
the sections (white circles). Similarly, scaffolds seeded with MSC/HUVEC showed co-staining for pericyte markers (d, 
e, f, white circles), indicating that these tubular structures also involved pericytes. Negative controls (primary antibody 
omitted) are shown in g and h, and the overall cell repartition is visible due to DAPI counter-staining. Consecutive 
sections were around 100 µm from each other (Scale bar = 50 µm).
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Fig. 8. Quantification of tubular-like structures. The presence of cell reorganisation was manually counted by 2 
different observers. Five fields of view were counted per section from each sample (2 sections per sample, 2 samples 
per donor). Counting was performed on toluidine blue stained sections (a) or on sections stained for PECAM-1, 
vWF and CD146 (b).
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Discussion
In the context of large bone defects, tissue-engineering 
approaches have become the most promising alternative 
to the actual gold standard, namely autologous bone graft. 
However, the microvasculature network required for the in 
vivo survival, maintenance and function of such constructs 
is still a problem. Neovascularisation is a time-consuming 
process, as blood vessels grow in from surrounding 
tissues by angiogenesis (Laschke and Menger, 2012). This 
multistep process involves the ability of endothelial cells 
to sprout out from pre-existing microvessels and extend 
toward the implanted tissue. In most large defect cases, this 
physiological growth is too slow (about 5 µm/h) to ensure 
perfusion, and consequently only the periphery of the 
implant is usually vascularised. Therefore, the presence of 
pre-vascular networks inside tissue-engineered constructs 
is essential for getting a faster blood supply through the 
implant.
 The aim of the present study was to investigate the 
ability of EPCs co-cultured with MSCs to develop a pre-
capillary network within 3D PU scaffolds for bone tissue 
engineering applications. In addition to optimising the two 
cell populations’ association, we also describe an improved 
3D culture environment for both EPCs and MSCs. When 
cultured in vitro and in the presence of angiogenic factors, 
endothelial cells from capillary origin have shown the 
ability to spontaneously form luminal microcapillary-like 
networks in vitro (Folkman and Haudenschild, 1980). Some 
other studies showed the beneficial effect of co-culturing 
mature endothelial cells (microvascular or HUVEC) with 
other cells types (fibroblast, myofibroblast, MSC) (Sato 
et al., 1987; Berthod et al., 2006; Tsigkou et al., 2010). 
Those cells serve as mural cells, and secrete an extracellular 
matrix necessary for the new vessel stabilisation (Kubota 
et al., 1988; Hoying et al., 1996).
 Here, we show that endothelial progenitor cells (EPC) 
isolated from human bone marrow samples are able to 
rapidly form cellular networks when cultured on basement 
membrane protein coatings (Growth factor reduced 
MatrigelTM). In contrast, when cultured on the same 
coatings, neither MSCs nor EPC-depleted MSC (MM) 
fractions developed such cellular complexes. However, 
when EPCs were reintroduced to those cell populations, 
a rapid and well-structured cellular network was clearly 
observed involving both EPCs and cells from the MSC 
fraction. Of particular interest, the same was observed when 
EPCs were added to the MM cell fraction (EPC-depleted). 
Previous investigations on neovascular scaffolding (Maier 
et al., 2010; Killingsworth and Wu, 2011) revealed the 
affiliation of CD146-positive pericytes as an important 
part of the neovascular structure. This is in line with Au 
et al. (Au et al., 2008) who described the contribution of 
MSCs to the overall stability of newly formed capillaries 
as providing the structure with perivascular cells. It 
was also shown that MSCs and pericytes share similar 
gene setups, indicating a close relationship in terms of 
differentiation patterns (Covas et al., 2008; Crisan et al., 
2008; Caplan and Correa, 2011; Feng et al., 2011). In our 
study using a CD146-specific antibody, we first detected 
positive staining after 1 week of co-culture, especially in 
the cells from the MSC or MM populations participating 
toward those networks. Thus, the differentiation of the 
MSC/MM towards CD146-expressing cells results from 
the direct cell-cell interaction between mesenchymal stem 
cells and either EPCs or HUVECs. When seeded in 3D 
polyurethane scaffolds, MSC-EPC co-cultures clearly 
showed the presence of cells reorganising into luminal 
tubular structures already after 7 days of incubation 
in media containing both angiogenic and osteogenic 
factors (Medium 3 and Medium 4). These capillary-like 
assemblies were positive not only for endothelial cell 
markers like PECAM-1 and vWF, but also for CD146, 
commonly expressed by pericytes. To date, pericytes 
(mural cells and/or adventitial cells, but different from 
EPCs, endothelial cells and smooth muscle cells) are still 
poorly characterised (Sims, 2000; Bondjers et al., 2006). 
Although NG2, αSMA and CD146 have been shown to be 
present on cells associated with blood vessels (Nehls and 
Drenckhahn, 1991; Schlingemann et al., 1991; Ozerdem 
et al., 2005; Bondjers et al., 2006), none of these markers 
are exclusive for pericytes. However, the combination of 
the three tends to confirm the pericyte phenotype. As we 
performed some immunostaining using antibodies specific 
to NG2 and αSMA, we observed not only some positive 
signal at the periphery of the tubular structures, but in other 
areas, due to the fact that those markers can be expressed in 
various cell types. Of particular interest was our sequential 
sectioning of scaffolds in which we could identify areas 
where each of the three antibodies were detected, and 
always in association with tubular structures. This was 
more obvious when mature endothelial cells (HUVECs) 
were used in the constructs as compared to the scaffolds 
containing endothelial progenitor cells (less differentiated 
than HUVECs). MSCs cultured on their own showed their 
incapacity in forming pre-vascular networks, confirming 
previous observations by Au et al. (Au et al., 2008). 
When 25 % of EPCs were added to the MSCs, a fast (7 
days in culture) and clear formation of stabilised tubular 
structures was observed, involving both vWF-CD31 
double-positive cells and pericyte-like cells. The number 
of these structures increased slightly when a higher EPCs 
percentage was added (50 %). When EPCs were seeded 
alone, no pre-vascular network could be observed in 3D, 
indicating a major role of MSCs in the differentiation of 
EPCs towards a more mature endothelial cell phenotype 
able to form stable a pre-vascular network.
 Although the direct mechanisms of tubular-like 
structure formation in co-culture of MSCs and EPCs are 
still unknown, it has been shown that mature endothelial 
cells and osteoblasts affect proliferation, as well as 
differentiation of each other. Growth factors such as BMP-
2 and IGF released by endothelial cells affect osteoblast 
proliferation and differentiation (Bouletreau et al., 2002; 
Kaigler et al., 2003; Huang et al., 2005). In return, 
osteoblasts are able to increase endothelial cell viability, 
proliferation and angiogenesis, by releasing high levels 
of VEGF (Deckers et al., 2002; Kaigler et al., 2003). In 
the absence of MSCs, we observed a decreased number of 
EPCs and of HUVECs after 7 days in 3D culture (data not 
shown), a phenomenon also described by others (Hofmann 
et al., 2008). Endothelial cells are known to die rapidly 
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if attachment and spreading are impaired (Unger et al., 
2007). In our case, microvessel-like structures could only 
be observed when dexamethasone, known to stimulate in 
vitro osteogenic differentiation and extracellular matrix 
production of MSC (Leboy et al., 1991), was added to 
the culture medium (Medium 3 and Medium 4). Several 
studies showed the positive effect of growth factors 
released by PRP on the proliferation and differentiation 
of osteoblasts and endothelial cells (Lucarelli et al., 2005; 
Lev et al., 2006; Lin et al., 2006; Roussy et al., 2007; 
Verrier et al., 2010; Lippross et al., 2011). It has also been 
described that endothelial cells in co-culture can attach 
to extracellular matrix proteins produced by osteoblasts 
or directly to osteoblasts (Stein et al., 1990; Unger et 
al., 2007), while proliferating MSCs co-cultured with 
HUVECs do not support the neovascularisation process 
(Tsigkou et al., 2010). Taken together, this confirms the 
dual function of the MSCs in the production of neovascular 
networks in 3D constructs. On one hand, they support 
the neovascularisation process as they differentiate 
toward osteoblast-like cells, and on the other hand, they 
participate in the stabilisation of newly formed capillaries 
as perivascular cells.
Conclusion
In conclusion, we showed the potent effect Endothelial 
Progenitor Cells in promoting in vitro pre-vascularisation 
within 3D scaffolds when co-cultured with Mesenchymal 
Stem Cells. MSCs were shown to play at least two distinct 
roles in this process. The presence of MSCs in osteogenic 
medium supports the differentiation of EPCs towards a 
more mature endothelial cell phenotype. In addition, as 
proven by the detection of pericyte markers on MSCs 
associated with the newly formed tubular structures, they 
also participate in the overall stabilisation of the vessels. 
This pre-vascular network could be seen as early as 7 
days, when the scaffolds were cultured in the presence 
of both angiogenic and osteogenic factors in the medium 
(media 3 and 4). The presence of such pre-capillary 
networks throughout 3D scaffolds prior to implantation is 
of real interest, as anastomosis with pre-existing luminal 
structures is a much faster process than capillary invasion 
from surrounding tissues. Our next step is to investigate 
the functionality of these pre-vascularised constructs when 
implanted in vivo.
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Discussion with Reviewers
M. Laschke: Regarding the MSC population, did you 
perform any characterisation?
Authors: In our laboratory, we have about 15 years 
of experience using MSC isolated this way. Indeed, in 
several parallel studies and regular test of foetal calf serum 
batches, we do evaluate the differentiation of these MSC 
toward chondrogenic and adipogenic phenotypes as well. 
In order not to over load the present manuscript, the MSC 
characterisation was not included. Moreover as published 
by Whitney et al. (2009) (additional reference), to date, 
there is not real CD marker to characterise MSC, therefore 
their ability to differentiate into chondrocyte, adipocyte and 
osteoblast seems to be the most adequate.
M. Laschke: You state that you found vessel-like structures 
with a lumen in their constructs. How can you be sure 
that this was a real lumen and not a simple histological 
artefact? A real lumen would be surrounded by a layer of 
endothelial cells. Accordingly, I suggest the performing 
of much more detailed morphological analyses of the 
vessel-like structures. For instance, this may be achieved 
by additional electron microscopic imaging.
Authors: Due to the persistence of the lumen over multiple 
serial sections, we consider that the structures are luminal 
vessel-like structures. Moreover, PECAM staining really 
showed the presence of endothelial cells around these 
structures, supported by the presence of cells showing 
pericyte markers. We will, however, definitely perform 
electron microscopy imaging in further studies.
M. Laschke: Proof is missing that the observed tubular 
vessel-like structures would have any function under in vivo 
conditions, which, at least for later clinical applications, is 
the most important question to clarify. Please comment. 
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Authors: This point is currently under investigation 
through an in vivo nude mice sub-cutaneous implantation 
study.
S. Fuchs: In Fig. 7 you highlighted areas in co-cultures of 
CD34/ MSCs which do not meet the definition of a vascular 
lumen. In addition, staining for CD146 marks endothelial 
cells in accordance with CD146 expression by endothelial 
cells, which are highly abundant in the HUVEC/ MSC 
culture but nearly absent in CD34/ MSCs.
Authors: We agree that it is difficult to recognise any 
well-defined structures (e.g., lumen) in the EPC/MSC 
co-culture scaffolds. The staining presented in Fig. 7 
is specific for CD146, NG2 and αSMA. None of these 
markers is exclusively expressed on pericyte cells, but the 
combination of them is a strong indication of the pericyte 
phenotype. HUVEC cells are more mature endothelial 
cells when compared with EPC. Therefore, they are able to 
develop more mature luminal structures when co-cultured 
with MSC (none of such structures were observed when 
HUVEC were cultured on their own).
S. Fuchs: CD146 is a marker expressed on mature 
endothelial cells but is also discussed to play a role 
in the stabilisation of vascular structures and can be 
expressed in pericyte-like cells. Thus, this marker is very 
ambiguous to evaluate the origin of pericytes, especially 
in the experimental settings chosen by the authors. In 
consequence, the presented data are not completely 
evident and conclusions regarding the origin of pericyte-
like cells need further experimental support. This is also 
accompanied by two major obstacles for this study. On one 
hand the vascular structures formed by CD34 positive cells 
under “more stringent angiogenesis conditions” (fibrin/
scaffolding material) seem to be much lower in number and 
less structured when compared to the HUVECs. Although 
the direct quantitative comparison of vascular structures 
of MSC/CD34 cells and MSC/HUVEC cells is missing, 
this is reflected by the figures. These poorly organised 
vascular structures shown for CD34/MSC cultures make 
studies on the grade of vascular stabilisation very difficult. 
In addition, also more co-stainings for endothelial markers 
and pericyte markers in morphologically well defined 
vascular structures in co-cultures of CD34 and MSCs 
would be needed.
Authors: Indeed, the CD146 marker has been shown to be 
expressed in mature endothelial cells as well as in other cell 
types (for instance in pericytes). Therefore we also looked 
at some other markers (NG2, αSMA), that are not specific 
to pericytes either, but the combination of them makes our 
hypothesis that cells participating to the tubular network 
are pericyte-like cells more convincing.
S. Fuchs: How many CD34 positive cells can be isolated 
in average from the bone marrow from one donor and do 
you see a high donor to donor variation for harvesting 
effectiveness or the biological performance of the cells? 
Authors: We indeed observed some donor to donor 
variations in 22 donors tested. The content of CD34 
positive cells tends to decrease with age from about 4 % 
of the post-Ficoll cell population (at the age of 30 years) 
towards 0.5 % (for samples from donors above 70). 
However, concerning the biological performance of these 
cells, we so far never noticed any correlation between the 
age of the patient and the ability of the cells to grow or 
form tubular structures.
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